| Digestive System Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 231show all (up to 200) |
|---|
| → investigated in trials for | Fluorouracilsmall molecule 209 trials (76 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 209 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 209 trials (80 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 209 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 196 trials (67 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 196 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 178 trials (12 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 178 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 172 trials (81 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 172 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 145 trials (52 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 145 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 139 trials (54 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 139 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 136 trials (59 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 136 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 122 trials (51 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 122 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 113 trials (44 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 113 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 112 trials (50 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 100 trials (43 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 79 trials (50 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 79 trials (39 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 76 trials (47 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 72 trials (30 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 61 trials (33 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 49 trials (26 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 48 trials (21 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 47 trials (20 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 42 trials (29 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 40 trials (13 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 36 trials (14 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 35 trials (17 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 35 trials (15 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 34 trials (11 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 33 trials (17 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 32 trials (12 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 31 trials (10 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 28 trials (6 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 24 trials (11 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 24 trials (6 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 23 trials (12 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zolbetuximabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Catumaxomabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onatasertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Refametinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tepotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azathioprinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Birabresibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Pemetrexed Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Conatumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Derazantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FGFR4 Inhibitor H3B-6527 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fisogatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfacon-1other 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | L19IL2 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | MTOR Kinase Inhibitor AZD8055 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Digestive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |